Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

Clin Transl Med. 2022 Aug;12(8):e1018. doi: 10.1002/ctm2.1018.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Immunological* / pharmacology
  • Antineoplastic Agents, Immunological* / therapeutic use
  • B7-H1 Antigen / therapeutic use
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use
  • Lung Neoplasms* / drug therapy

Substances

  • Antineoplastic Agents, Immunological
  • B7-H1 Antigen
  • Immune Checkpoint Inhibitors